NASDAQ:LFST LifeStance Health Group (LFST) Stock Price, News & Analysis $12.15 -0.13 (-1.06%) As of 04:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About LifeStance Health Group Stock (NASDAQ:LFST) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LFST alerts:Sign Up Key Stats Today's Range$12.01▼$12.4850-Day Range$8.61▼$12.8352-Week Range$4.77▼$12.97Volume4.29 million shsAverage Volume4.30 million shsMarket Capitalization$4.71 billionP/E Ratio94.46Dividend YieldN/APrice Target$12.38Consensus RatingModerate Buy Company Overview LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans. The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services. Clinicians at LifeStance employ a range of therapeutic approaches—such as cognitive behavioral therapy (CBT), dialectical behavior therapy (DBT), and trauma-informed care—to address conditions including anxiety, depression, attention-deficit/hyperactivity disorder (ADHD), and other mental health challenges. Telehealth options further enhance access for patients facing geographic or scheduling limitations. LifeStance partners with health plans, employer-sponsored programs, and governmental payers to integrate its services into broader healthcare ecosystems. These collaborations facilitate in-network access through major insurance carriers and support employer wellness initiatives aimed at improving workforce mental health. Since its inception, the company has expanded both organically and through strategic acquisitions to establish a broad national footprint and meet the increasing demand for outpatient behavioral health services. AI Generated. May Contain Errors. Read More LifeStance Health Group Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreLFST MarketRank™: LifeStance Health Group scored higher than 67% of companies evaluated by MarketBeat, and ranked 329th out of 917 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.5 / 5Analyst RatingModerate Buy Consensus RatingLifeStance Health Group has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 6 buy ratings, 4 hold ratings, and no sell ratings.Upside/DownsideThe consensus price target for LifeStance Health Group is close to its current price, suggesting limited near-term upside or downside.Amount of Analyst CoverageLifeStance Health Group has been the subject of 8 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about LifeStance Health Group's stock forecast and price target. Earnings and Valuation2.5 / 5Proj. Earnings Growth43.75% Earnings GrowthEarnings for LifeStance Health Group are expected to grow by 43.75% in the coming year, from $0.16 to $0.23 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of LifeStance Health Group is 93.47, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 39.20.Price to Earnings Ratio vs. SectorThe P/E ratio of LifeStance Health Group is 93.47, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.49.Price to Book Value per Share RatioLifeStance Health Group has a P/B Ratio of 3.19. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.Read more about LifeStance Health Group's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.05% of the float of LifeStance Health Group has been sold short.Short Interest Ratio / Days to CoverLifeStance Health Group has a short interest ratio ("days to cover") of 2.01, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in LifeStance Health Group has recently increased by 19.35%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldLifeStance Health Group does not currently pay a dividend.Dividend GrowthLifeStance Health Group does not have a long track record of dividend growth. News and Social Media3.7 / 5News Sentiment0.99 News SentimentLifeStance Health Group has a news sentiment score of 0.99. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.87 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 7 news articles for LifeStance Health Group this week, compared to 4 articles on an average week.Search InterestOnly 2 people have searched for LFST on MarketBeat in the last 30 days. This is a decrease of -87% compared to the previous 30 days.MarketBeat Follows3 people have added LifeStance Health Group to their MarketBeat watchlist in the last 30 days. This is an increase of 200% compared to the previous 30 days. Company Ownership1.6 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, LifeStance Health Group insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $154,952,012.00 in company stock.Percentage Held by Insiders3.50% of the stock of LifeStance Health Group is held by insiders.Percentage Held by Institutions85.50% of the stock of LifeStance Health Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about LifeStance Health Group's insider trading history. Receive LFST Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LifeStance Health Group and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LFST Stock News HeadlinesLifeStance: A Rare Outperformer In The Tricky Virtual Mental Healthcare SpaceAugust 24 at 9:52 AM | seekingalpha.comAnalysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Lifestance Health Group (LFST)August 23 at 1:04 AM | theglobeandmail.comA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money network by April 2027. BlackRock CEO Larry Fink already calls it 'the next major evolution in market infrastructure.' Our research has identified one small, overlooked position at the center of this policy-driven shift - already drawing quiet institutional buying from BNY Mellon, State Street, and JPMorgan. It currently trades for pennies relative to where institutional demand could push it. The Q3 2026 compliance deadline may be the last window before prices move.August 26 at 1:00 AM | Awesomely (Ad)LifeStance Health Group (NASDAQ:LFST) Price Target Raised to $13.00August 17, 2026 | americanbankingnews.comLifeStance Health Group, Inc. (NASDAQ:LFST) Given Consensus Recommendation of "Moderate Buy" by BrokeragesAugust 16, 2026 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) Upgraded by Wall Street Zen to "Strong-Buy" RatingAugust 15, 2026 | americanbankingnews.comLifeStance Health Group (NASDAQ:LFST) CTO Sells $481,674.90 in StockAugust 13, 2026 | insidertrades.comMorgan Stanley Reaffirms Their Buy Rating on Lifestance Health Group (LFST)August 12, 2026 | theglobeandmail.comSee More Headlines LFST Stock Analysis - Frequently Asked Questions How have LFST shares performed this year? LifeStance Health Group's stock was trading at $7.04 on January 1st, 2026. Since then, LFST shares have increased by 72.6% and is now trading at $12.15. How were LifeStance Health Group's earnings last quarter? LifeStance Health Group, Inc. (NASDAQ:LFST) released its quarterly earnings data on Thursday, August, 6th. The company reported $0.06 EPS for the quarter, beating the consensus estimate of $0.03 by $0.03. LifeStance Health Group's revenue was up 26.1% compared to the same quarter last year. Read the conference call transcript. Is LifeStance Health Group doing a stock buyback? LifeStance Health Group's board authorized a share repurchase plan on Wednesday, February 25th 2026, which allows the company to buy back $100,000,000 in outstanding shares, according to EventVestor. This means that the company could repurchase up to 3.6% of its shares through open market purchases. Shares buyback plans are generally an indication that the company's management believes its shares are undervalued. When did LifeStance Health Group IPO? LifeStance Health Group (LFST) raised $640 million in an initial public offering (IPO) on Wednesday, June 9th 2021. The company issued 40,000,000 shares at $15.00-$17.00 per share. Morgan Stanley, Goldman Sachs, J.P. Morgan, Jefferies, TPG Capital BD LLC, UBS Investment Bank and William Blair served as the underwriters for the IPO and Capital One Securities, AmeriVet, Drexel Hamilton, R. Seelaus & Co. and Siebert Williams Shank were co-managers. Who are LifeStance Health Group's major shareholders? LifeStance Health Group's top institutional investors include BlackRock Inc. (9.37%), UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC (1.53%), Wellington Management Group LLP (0.74%) and California State Teachers Retirement System (0.66%). Insiders that own company stock include Tpg Gp A, Llc, Summit Partners Growth Equity, Summit Partners L P, Darren M Black, Silversmith Partners I Gp, Llc, Warren Gouk, Kevin Michael Mullins, Eric Shuey, Robert Bessler, Danish J Qureshi, David Bourdon, Ann Varanakis, Lisa K Miller, Vukasin Paunovich, Paula Cipollone and Ujjwal Ramtekkar. View institutional ownership trends. How do I buy shares of LifeStance Health Group? Shares of LFST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LifeStance Health Group own? Based on aggregate information from My MarketBeat watchlists, some other companies that LifeStance Health Group investors own include Waste Connections (WCN), American Water Works (AWK), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and Triple Flag Precious Metals (TFPM). Company Calendar Last Earnings8/06/2026Today8/26/2026Next Earnings (Estimated)11/05/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (12m+) 1-Year History Aug 25 Nov 25 Feb 26 May 26 Aug 26 LFST's financial health is in the Green zone, according to TradeSmith. LFST has been in this zone for over 12 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryHealthcare Services Current SymbolNASDAQ:LFST CIK1845257 Webwww.lifestance.com Phone602-767-2100FaxN/AEmployees10,961Year Founded2017Price Target and Rating Average Price Target for LifeStance Health Group$12.38 High Price Target$18.00 Low Price Target$8.00 Potential Upside/Downside+1.9%Consensus RatingModerate Buy Rating Score (0-4)2.73 Research Coverage11 Analysts Profitability EPS (Trailing Twelve Months)$0.13 Trailing P/E Ratio93.47 Forward P/E Ratio75.94 P/E GrowthN/ANet Income$9.66 million Net Margins3.19% Pretax Margin4.23% Return on Equity3.39% Return on Assets2.33% Debt Debt-to-Equity Ratio0.18 Current Ratio1.38 Quick Ratio1.38 Sales & Book Value Annual Sales$1.42 billion Price / Sales3.31 Cash Flow$0.17 per share Price / Cash Flow72.29 Book Value$3.81 per share Price / Book3.19Miscellaneous Outstanding Shares387,830,000Free Float374,260,000Market Cap$4.71 billion OptionableOptionable Beta1.14 Social Links The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (NASDAQ:LFST) was last updated on 8/26/2026 by MarketBeat.com Staff. From Our PartnersBezos… DOOMEDA single FCC filing hints Elon Musk is planning his biggest project yet - bigger than Tesla, SpaceX, and X com...Paradigm Press | SponsoredSomeone just dumped the biggest gold fund.Investors pulled 2.9 billion dollars from the world's largest gold fund in a single day this March, pushing to...Behind the Markets | SponsoredA $382 trillion migration and the position no one is talking aboutTrump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...Awesomely | SponsoredYour book attachedYour Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...Profits Run | SponsoredYour withdrawal order could cost you in taxesIf you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...SmartAsset | SponsoredThe trade I’ve been waiting for since 2011Ross Givens, Director of Research at Traders Agency, is calling for gold to reach $10,000 an ounce this superc...Traders Agency | SponsoredJeff Brown and Marc Chaikin's latest AI prediction explainedJeff Brown and Marc Chaikin - the duo who identified Nvidia a decade ago - are forecasting that Elon Musk's AI...Brownstone Research | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LifeStance Health Group, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LifeStance Health Group With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
